{"id":"NCT01229397","sponsor":"Crucell Holland BV","briefTitle":"Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V","officialTitle":"A Phase III Open, Randomized, Parallel, Multi-center Study in Children Aged 6 - 35 Months to Compare the Immunogenicity and Safety of a Single 0.5 mL Dose of Inflexal V With a 0.25 mL 2-dose Regimen of Inflexal V Administered According to a 0/4 Week Schedule","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-10","primaryCompletion":"2010-11","completion":"2010-11","firstPosted":"2010-10-27","resultsPosted":"2013-05-20","lastUpdate":"2014-02-06"},"enrollment":205,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Inflexal V","otherNames":[]},{"type":"BIOLOGICAL","name":"Inflexal V","otherNames":[]}],"arms":[{"label":"Inflexal V 0.25 mL x 2","type":"ACTIVE_COMPARATOR"},{"label":"Inflexal V 0.5 mL x 1","type":"EXPERIMENTAL"}],"summary":"The study aims to evaluate the immunogenicity of a single full (0.5 mL) dose and a 0.25 mL 2-dose regime of Inflexal V in unprimed children aged 6 - \\<36 months, using the EMA guideline for the re-registration of the seasonal influenza vaccine in adults (aged ≥18 ≤60 years) as reference.","primaryOutcome":{"measure":"Immunogenicity of a Single Full (0.5 mL) Dose and a 0.25 mL 2-dose Regimen of Inflexal V, Using the EMA Guideline for the Re-registration of the Seasonal Influenza Vaccine in Adults (Aged ≥18 to ≤60 Years) as Reference","timeFrame":"This assesment was done for immunogenicity data collected at Day 29 after completion of designated vaccination regimen","effectByArm":[{"arm":"Inflexal V 0.25 mL x 2","deltaMin":99,"sd":null},{"arm":"Inflexal V 0.5 mL x 1","deltaMin":98,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":15},"locations":{"siteCount":2,"countries":["Italy"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":102},"commonTop":["Pyrexia","Erythema (at the injection site)","Pyrexia","Pain (at the injection site)","Malaise"]}}